Literature DB >> 24529391

Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs.

Lin Zhu1, Federico Perche2, Tao Wang2, Vladimir P Torchilin3.   

Abstract

Co-delivery of hydrophilic siRNA and hydrophobic drugs is one of the major challenges for nanomaterial-based medicine. Here, we present a simple but multifunctional micellar platform constructed by a matrix metalloproteinase 2 (MMP2)-sensitive copolymer (PEG-pp-PEI-PE) via self-assembly for tumor-targeted siRNA and drug co-delivery. The micellar nanocarrier possesses several key features for siRNA and drug delivery, including (i) excellent stability; (ii) efficient siRNA condensation by PEI; (iii) hydrophobic drug solubilization in the lipid "core"; (iv) passive tumor targeting via the enhanced permeability and retention (EPR) effect; (v) tumor targeting triggered by the up-regulated tumoral MMP2; and (vi) enhanced cell internalization after MMP2-activated exposure of the previously hidden PEI. These cooperative functions ensure the improved tumor targetability, enhanced tumor cell internalization, and synergistic antitumor activity of co-loaded siRNA and drug.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Matrix metalloproteinase; Polymeric micelles; Self-assembly; Stimulus-sensitive; Tumor targeting; siRNA and drug delivery

Mesh:

Substances:

Year:  2014        PMID: 24529391      PMCID: PMC3981970          DOI: 10.1016/j.biomaterials.2014.01.060

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  25 in total

1.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.

Authors:  G Ambrosini; C Adida; D C Altieri
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

Review 2.  Cell-penetrating peptides: mechanism and kinetics of cargo delivery.

Authors:  Matjaz Zorko; Ulo Langel
Journal:  Adv Drug Deliv Rev       Date:  2005-01-22       Impact factor: 15.470

3.  Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer.

Authors:  Yong Wang; Shujun Gao; Wen-Hui Ye; Ho Sup Yoon; Yi-Yan Yang
Journal:  Nat Mater       Date:  2006-09-24       Impact factor: 43.841

4.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

Authors:  Dmitri B Kirpotin; Daryl C Drummond; Yi Shao; M Refaat Shalaby; Keelung Hong; Ulrik B Nielsen; James D Marks; Christopher C Benz; John W Park
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

5.  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.

Authors:  Marcin Kortylewski; Maciej Kujawski; Tianhong Wang; Sheng Wei; Shumin Zhang; Shari Pilon-Thomas; Guilian Niu; Heidi Kay; James Mulé; William G Kerr; Richard Jove; Drew Pardoll; Hua Yu
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

Review 6.  Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.

Authors:  Daniel De Paula; M Vitória L B Bentley; Ram I Mahato
Journal:  RNA       Date:  2007-02-28       Impact factor: 4.942

7.  Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.

Authors:  Shyh-Dar Li; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

8.  Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer.

Authors:  G Salzano; R Riehle; G Navarro; F Perche; G De Rosa; V P Torchilin
Journal:  Cancer Lett       Date:  2013-10-04       Impact factor: 8.679

9.  RNA interference targeting Fas protects mice from fulminant hepatitis.

Authors:  Erwei Song; Sang-Kyung Lee; Jie Wang; Nedim Ince; Nengtai Ouyang; Jun Min; Jisheng Chen; Premlata Shankar; Judy Lieberman
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

Review 10.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.

Authors:  Anatoly N Lukyanov; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2004-05-07       Impact factor: 15.470

View more
  33 in total

Review 1.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

2.  Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.

Authors:  Francois Fay; Line Hansen; Stefanie J C G Hectors; Brenda L Sanchez-Gaytan; Yiming Zhao; Jun Tang; Jazz Munitz; Amr Alaarg; Mounia S Braza; Anita Gianella; Stuart A Aaronson; Thomas Reiner; Jørgen Kjems; Robert Langer; Freek J M Hoeben; Henk M Janssen; Claudia Calcagno; Gustav J Strijkers; Zahi A Fayad; Carlos Pérez-Medina; Willem J M Mulder
Journal:  Bioconjug Chem       Date:  2017-05-05       Impact factor: 4.774

3.  Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer.

Authors:  Tao Wang; Radhika Narayanaswamy; Huilan Ren; James W Gillespie; Valery A Petrenko; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2017-12-01       Impact factor: 5.121

Review 4.  siRNA Delivery by Stimuli-Sensitive Nanocarriers.

Authors:  Giuseppina Salzano; Daniel F Costa; Vladimir P Torchilin
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Fabrication of magnetic nanochains linked with CTX and curcumin for dual modal imaging detection and limitation of early tumour.

Authors:  Yuedi Yang; Zhongbing Huang; Ximing Pu; Guangfu Yin; Lei Wang; Fabao Gao
Journal:  Cell Prolif       Date:  2018-08-21       Impact factor: 6.831

Review 6.  Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

Authors:  Zhihang Chen; Balaji Krishnamachary; Jesus Pachecho-Torres; Marie-France Penet; Zaver M Bhujwalla
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-23

Review 7.  Nanoscale delivery systems for microRNAs in cancer therapy.

Authors:  Sanda Boca; Diana Gulei; Alina-Andreea Zimta; Anca Onaciu; Lorand Magdo; Adrian Bogdan Tigu; Calin Ionescu; Alexandru Irimie; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

8.  Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors.

Authors:  Tao Wang; Shenghong Yang; Leslie A Mei; Chirag K Parmar; James W Gillespie; Kulkarni P Praveen; Valery A Petrenko; Vladimir P Torchilin
Journal:  Mol Cancer Ther       Date:  2014-09-19       Impact factor: 6.261

Review 9.  Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.

Authors:  Jinho Park; Joonyoung Park; Yihua Pei; Jun Xu; Yoon Yeo
Journal:  Adv Drug Deliv Rev       Date:  2015-12-10       Impact factor: 15.470

Review 10.  Micelle-like nanoparticles as carriers for DNA and siRNA.

Authors:  Gemma Navarro; Jiayi Pan; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2015-01-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.